Organisation paid for research Program year 2022 Source: CMS Open Payments

Palmetto Research

Neither a doctor nor a teaching hospital

Research payments

$115,000

5 payments

Through program year 2022, Palmetto Research is reported as receiving $115,000 in research payments, across 5 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $1,000 1
2021 Research $28,675 1
2020 Research $83,525 1
2019 Research $1,800 2

Breakdown

Who paid Research payments · program years 2019–2022
  1. Provepharm Inc. $113,200 3 payments
  2. Merck Sharp & Dohme Corporation $1,800 2 payments
Studies the money was for Research payments · program years 2019–2022
  1. Pvp-Ic1901 $113,200 3 payments
  2. HPS 3 , TIMI 55 REVEAL Randomized EValuation of the Effects of Anacetrapib through Lipid-modification A large-scale, randomized placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease. $1,800 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record